Chemical inhibitors make their RNA epigenetic mark

RNA epigenetic drug development enters a new era, as companies start revealing targets and evidence of preclinical efficacy.

Search for this author in:

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.

Nature Reviews Drug Discovery 18, 892-894 (2019)

Updates & Corrections

  • Correction 25 October 2019: The text, figure, and figure legend have been corrected to clarify that FTO demethylates m6A on mRNA as well as m6Am on snRNA.

Nature Briefing

An essential round-up of science news, opinion and analysis, delivered to your inbox every weekday.